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COMMENTARY Open Access
Triple P-Positive Parenting programs: the folly of
basing social policy on underpowered flawed
studies
James C Coyne1,2* and Linda Kwakkenbos3,4
Abstract
Wilson et al. provided a valuable systematic and meta-
analytic review of the Triple P-Positive Parenting
program in which they identified substantial problems
in the quality of available evidence. Their review largely
escaped unscathed after Sanders et al.’s critical
commentary. However, both of these sources overlook
the most serious problem with the Triple P literature,
namely, the over-reliance on positive but substantially
underpowered trials. Such trials are particularly
susceptible to risks of bias and investigator
manipulation of apparent results. We offer a justification
for the criterion of no fewer than 35 participants in
either the intervention or control group. Applying this
criterion, 19 of the 23 trials identified by Wilson et al.
were eliminated. A number of these trials were so small
that it would be statistically improbable that they would
detect an effect even if it were present. We argued that
clinicians and policymakers implementing Triple P
programs incorporate evaluations to ensure that goals
are being met and resources are not being squandered.
Please see related articles http://www.biomedcentral.
com/1741-7015/10/130 and http://www.
biomedcentral.com/1741-7015/10/145
Keywords: meta-analysis, publication bias, conflict of
interest, dissemination, confirmatory bias
Commentary
Wilson and colleagues [1] provided a great service to
behavioral science and public policy by identifying ser-
ious limitations in the quality of evidence usually uncri-
tically cited in support of the effectiveness of Triple
P-Parenting programs. Using tools that can be readily
applied by others, they showed the heavy reliance on
self-referred, media-recruited two-parent families; a lack
of comparisons between Triple P and alternative active
treatments; assessment of outcomes with a battery of
measures with little or no evidence of a priori designa-
tion of a primary outcome; biased reporting of findings
in abstracts; and pervasive conflicts of interest with the
authors of the bulk of the articles receiving royalties and
other professional and financial rewards from the pro-
motion of Triple P.
A defensive rejoinder from the promoters of Triple P,
Sanders and colleagues [2], was disappointingly unrespon-
sive, particularly in light of the extravagant claims cur-
rently being made for empirical support on Triple P
websites [3,4] and in promotional material distributed
around the world. Some of the risks of bias in the Triple P
literature identified by Wilson and colleagues are indeed
endemic to literature evaluating psychosocial interven-
tions, but that does not excuse continuing promotion of
Triple P without explicit acknowledgment of the limita-
tions of the quantity and quality of available evidence. San-
ders and colleagues’ rejoinder underscores the problems of
relying on developers and promoters of interventions to
remain objective in evaluating their programs and in
receiving criticism.
Yet, both Wilson and colleagues and the response from
Sanders and colleagues overlook a fundamental weakness
in the Triple P literature that amplifies other sources of
bias. Namely, evidence consisting of studies with a high
risk of bias is further limited by the preponderance of
underpowered studies yielding positive results at a statisti-
cally improbable rate.
Wilson and colleagues noted a number of times in their
review that many of the trials are small, but they do not
dwell on how many, how small or with what implications.
We have adopted the lower limit of 35 participants in the
smallest group for inclusion of trials in meta-analyses [5].
The rationale is that any trial that is smaller than this does
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not have a 50% probability of detecting a moderate sized
effect, even if it is present. Moreover, small trials are sub-
ject to publication bias in that if results are not claimed to
be statistically significant, they will not get published with
the justification that the trial was insufficiently powered to
obtain a significant effect. On the other hand, when signifi-
cant results are obtained, they are greeted with great
enthusiasm precisely because the trials are so small. Small
trials, when combined with flexible rules for deciding
when to stop a trial (often based on a peek at the data),
failure to specify primary outcomes ahead of time, and
flexible rules for analyses, can usually be made to yield
positive findings that will not replicate. Small studies are
vulnerable to outliers and sampling error, and randomiza-
tion does not necessarily equalize group differences that
can prove crucial in determining results. Combining pub-
lished small trials in a meta-analysis does not overcome
these problems, because of publication bias and because of
all or many of the trials sharing methodological and
reporting problems [6].
What happens when we apply the exclusion criterion to
Triple P trials of less than 35 participants in the smallest
group? Looking at Table 2 in Wilson and colleagues’
review, we see that 19 of 23 of the individual papers
included in the meta-analyses are excluded. Figure 2 in
the Wilson et al. review provides the forest plot of effect
sizes for two of the key outcome measures reported in
Triple P trials. Small trials account for the outlying stron-
gest finding [7], but also the second-weakest finding [8], a
likely sampling error from inclusion of small trials. Meta-
analyses often attempt to control for the influence of small
trials by introducing weights, but this strategy is inade-
quate when the bulk of the trials are small [9]. Again
examining Figure 2, we see that even with the weights,
such small trials still add up to over 76% of the contribu-
tion to the overall effect size. Of the four trials that are not
underpowered [10-13], one [10] has a non-significant
effect entered into the meta-analysis. In addition, the con-
fidence interval for one of the positive, moderate-sized
trials barely excludes zero (.06) [11].
Many of the trials evaluating Triple P were quite small,
with eight trials having less than 20 participants (9 to 18)
in the smallest group. This is grossly inadequate to achieve
the benefits of randomization and such trials are extremely
vulnerable to reclassification or loss to follow-up or missing
data from one or two participants. Moreover, we are given
no indication how the investigators settled on an interven-
tion or control group this small. Certainly it could not have
been decided on the basis of an a priori power analysis,
raising concerns of data snooping [14] having occurred.
The consistently positive findings reported in the abstracts
of such small studies raise further suspicions that investiga-
tors have manipulated results by hypothesizing after the
results are known (harking) [15], cherry-picking and other
inappropriate strategies for handling and reporting data
[16]. Such small trials are statistically quite unlikely to
detect even a moderate-sized effect, and that so many
nonetheless get significant findings attests to a publication
bias or obligatory replication [17] being enforced at some
points in the publication process.
Many communities and charities are proceeding with
ambitious and costly implementations of Triple P-
Parenting programs with the expectation that this will
lead to the alleviation of social and public health
problems associated with poor parenting. Wilson and
colleagues highlighted the inadequacy of the existing
clinical trial data. Adding to that the dominance of biased
positive reporting of underpowered trials, it becomes
incumbent upon clinicians and policymakers to ade-
quately monitor the implementation of Triple P and
evaluation of clinical outcomes to ensure that scarce
resources are not squandered.
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